Selecting treatment options for TKI-resistant chronic myeloid leukemia Journal Article
| Author: | Mauro, M. J. |
| Article Title: | Selecting treatment options for TKI-resistant chronic myeloid leukemia |
| Keywords: | vasculotropin; cancer survival; gene mutation; overall survival; hydroxyurea; interferon; cancer risk; drug efficacy; drug safety; skin manifestation; cytarabine; imatinib; progression free survival; bone marrow suppression; clinical assessment; dasatinib; chronic myeloid leukemia; protein tyrosine kinase inhibitor; protein synthesis; cardiovascular disease; cerebrovascular disease; bcr abl protein; cytotoxic t lymphocyte antigen 4; nilotinib; homoharringtonine; programmed death 1 receptor; pulmonary hypertension; bosutinib; peripheral occlusive artery disease; ponatinib; human; article |
| Journal Title: | Clinical Advances in Hematology & Oncology |
| Volume: | 12 |
| Issue: | 7 Suppl. 13 |
| ISSN: | 1543-0790 |
| Publisher: | Millennium Medical Publishing, Inc |
| Date Published: | 2014-07-01 |
| Start Page: | 12 |
| End Page: | 16 |
| Language: | English |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Export Date: 2 October 2015 -- Source: Scopus |
MSK Authors
-
267Mauro